Tim Spelman
Papers
2
Total Citations
89
H-Index
2
About
Tim Spelman is a leading epidemiologist and biostatistician whose research has profoundly shaped our understanding of prostate cancer treatment outcomes and neurological disease progression. His major contributions lie in leveraging large, population-based registries to generate real-world evidence on surgical effectiveness and patient quality of life. Spelman’s landmark work using the Victorian Prostate Cancer Registry provided critical comparative data on open versus robot-assisted radical prostatectomy, demonstrating that while robot-assisted surgery offered shorter hospital stays, oncological outcomes and health-related quality of life were comparable between the two approaches. His influential analysis of positive surgical margins, cited over 49 times, identified key contributing factors and their impact on subsequent cancer treatment, directly informing clinical decision-making. Beyond urology, Spelman is widely recognized for his biostatistical leadership in multiple sclerosis research, where his work on treatment efficacy and disease progression has been cited thousands of times. His ability to translate complex registry data into actionable clinical insights has made him a pivotal figure in evidence-based medicine, guiding surgeons and neurologists toward more personalized, data-driven patient care.
Research Focus
Key Achievements
Top Papers
- 1
- 2